How Much Do Oncology Procedures Cost in Republic of Korea in AUD?
Oncology treatment in South Korea typically costs from AUD $21,100 to AUD $62,600. Final figures depend on the cancer stage, chosen technology like robotic systems, and the hospital tier. Patients generally save 30% to 70% compared to private healthcare costs in Australia.
Typical Oncology Costs in South Korea
- Consultation with an oncologist: AUD $59 – AUD $110
- PET/CT: AUD $1,600 – AUD $2,100
- MRI of one area: AUD $450 – AUD $790
- Bone marrow transplantation: AUD $133,500 – AUD $192,900
- Chemotherapy: AUD $2,800 – AUD $9,600
- Radiotherapy: AUD $11,900 – AUD $28,200
- CyberKnife: AUD $20,800 – AUD $28,200
- Brain tumour removal: AUD $22,300 – AUD $35,600
- Mastectomy: AUD $5,200 – AUD $20,800
- Proton-beam therapy: AUD $29,700 – AUD $47,500
Major medical hubs include Seoul, Bundang, and Suwon. Seoul-based university hospitals often charge 15–20% more than regional centres. For Australians, South Korea offers world-leading technology and much faster access to treatment than local public waitlists. Request a consultation with a specialist to get accurate pricing for your case.
| Republic of Korea | Thailand | Turkey | |
|---|---|---|---|
| Thyroid resection | from AUD $7,400 | ≈ AUD $8,200 | from AUD $3,700 |
| Stomach cancer surgery | from AUD $28,200 | ≈ AUD $16,300 | from AUD $12,600 |
| Removal of spinal cord tumor | ≈ AUD $23,700 | ≈ AUD $20,800 | from AUD $10,400 |
| Removal of liver cancer | from AUD $22,300 | ≈ AUD $17,800 | from AUD $17,800 |
| Removal of colon cancer | from AUD $23,700 | ≈ AUD $14,100 | from AUD $11,100 |
All Oncology conditions
Your Benefits and Guarantees with Bookimed
Transparent Prices & Flexible Installments
No hidden fees – just official clinic prices. Pay at the clinic for Oncology treatment upon arrival and use a flexible instalment plan if needed.
Verified Clinics & Doctors Only
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Oncology treatment and have the necessary licenses to serve international patients worldwide.
Free 24/7 Assistance
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Oncology treatment journey.

Your personal Bookimed medical coordinator
- Supports you at every stage
- Helps choose the right clinic and doctor
- Ensures quick and convenient access to information
Best Oncology Clinics in Republic of Korea for Australians: 29 Verified Options and AUD Prices
Top Oncology centres in Republic of Korea for Australians
- SAERO Plastic Surgery, Republic of Korea
- Yonsei JW Dental Clinic, Republic of Korea
- Samsung Medical Center, Republic of Korea
- Myongji Hospital, Republic of Korea
- VG Plastic Surgery, Republic of Korea
- JK Plastic Surgery Center, Republic of Korea
- Ewha Womans University Medical Center, Republic of Korea
- Gachon University Gil Medical Center, Republic of Korea
- Seoul National University Bundang Hospital (SNUBH), Republic of Korea
- Asan Medical Center, Republic of Korea
Our Trusted Doctors for Australian Patients
View all Doctors
Shin Hyuk Jai
Dr. Hyuk‑Jai Shin, MD, PhD, is a Clinical Professor of Surgery at Myongji Hospital in South Korea. He is also Director of the Breast Center and Vice President for Medical Affairs. His work focuses on breast cancer, benign breast disease, robotic and endoscopic breast surgery, and systemic therapy. He chairs the Korean Breast Cancer Society group for robotic and endoscopic minimally invasive surgery. He is a full member of ASCO.
He earned his MD and PhD from Dankook University. He completed a breast fellowship and served as a principal proteomics researcher at Seoul National University Hospital. He received endoscopic training at Kameda Hospital in Japan. He was an exchange professor at the University of Melbourne and a visiting surgeon at the Peter MacCallum Cancer Centre. He previously led the Breast & Thyroid Center and the Precision Medicine Center at Myongji Hospital. His publications include first‑author chapters in Translational Research in Breast Cancer (Chapter 30, pp. 567–590, Springer) and the Textbook of Surgical Ultrasound (Chapter 3‑3, VABB). He also co‑authored a nationwide VABB survey (Anticancer Research, 2012; 32(12):5459–64).

Kim Wan Song
Dr. Wan‑Sung Kim, MD, PhD, is Director of the Thyroid Center and an Associate Professor of Surgery at Myongji Hospital, an educational partner of Hanyang University. He is a breast and thyroid surgeon. He treats cancer and benign disease and focuses on minimally invasive thyroid and adrenal surgery.
Expertise: endoscopic and robotic thyroidectomy (transoral, axillary-areolar), thyroid radiofrequency ablation, ethanol ablation for thyroid lesions, and endoscopic or robotic adrenal tumor surgery.
He previously served as Head of Surgery at Myongji Hospital and Chuncheon Gangnam Hospital. He completed his residency and a breast and thyroid fellowship at Myongji. He holds an MD and MS from Catholic Kwandong University and a PhD from Kangwon National University. He is a member of the Korean Association of Thyroid and Endocrine Surgeons, the Korean Breast Cancer Society, the Korean Surgical Society, and the Korean Surgical Ultrasound Society.

Lee Chunyong
Dr. Lee Chunyong is a urologist with a PhD in Medicine from Hanyang University College of Medicine. His clinical focus includes kidney and urinary stones (ESWL), prostate diseases (BPH, prostate cancer, prostatitis), sexual dysfunction, vasectomy, cystitis, urinary incontinence, and voiding dysfunction.
He has served as Director of Hanyang University Hospital. He was Chairman and Chief Professor of the Department of Urology at Hanyang University College of Medicine. He served as President and later Honorary President of the Korean Endourological Society. He was also a Board Member of the Société Internationale d'Urologie.
His international roles include Visiting Fellow at UCLA and Visiting Professor at the University of Tübingen. He was featured twice on EBS “Best Doctors,” covering prostatic diseases and kidney and urinary stones.

Yu Yeonghun
Dr. Yu Yeonghun is a gastrointestinal surgeon with a Ph.D. in Medicine. He specializes in hepato-pancreato-biliary (HPB) diseases and cancers. His focus includes liver, pancreas, biliary tract, and gallbladder cancers, as well as cholelithiasis and other gallbladder diseases.
He completed his internship and general surgery residency at CHA Bundang Medical Center. He then finished an HPB surgery fellowship at Samsung Medical Center. He has served as Clinical Assistant Professor of Surgery at Konkuk University Choongju Hospital and at Samsung Medical Center. He later became Professor of Surgery at Eulji University Hospital.
He is a Lifetime Member of The Korean Surgical Society and the Korean Association of Hepato-Biliary-Pancreatic Surgery (KAHBPS). He serves on the KAHBPS Planning Committee and Tumor Registry Committee.
Video Stories from Bookimed Patients
Reviews about Bookimed: Discover Patients' Insights
All reviewsShare this content
Anna Leonova
FAQ about Oncology in Republic of Korea
How do survival rates for cancer treatments in the Republic of Korea compare to other countries?
The Republic of Korea reports a 73.7% overall 5-year relative cancer survival rate. This frequently outperforms other high-income nations. These outcomes are driven by mandatory national screening and high hospital volumes. Centres like Severance Hospital lead in robotic and targeted therapies.
- Stomach cancer survival: Rates reach 73.7%, significantly higher than the 32% reported in the USA.
- Thyroid cancer outcomes: Survival rates reach 100.2%, reflecting one of the highest clinical results globally.
- Prostate cancer survival: The 96.9% rate is comparable to or exceeding top-tier Western medical systems.
- Breast cancer success: A 94.7% survival rate surpasses the average benchmark for OECD nations.
Bookimed Expert Insight: Data suggests Korea’s survival advantage is linked to hospital volume and infrastructure. High-capacity centres like Severance Hospital and Samsung Medical Center treat over 2,000,000 patients annually. This massive scale allows doctors to specialise intensely. For example, Dr Paik Nam-sun at Ewha Womans University Medical Center is recognised globally for pioneering breast-conserving techniques. Large centres also use digital systems like BESTcare to reduce errors and start treatment faster.
Patient Consensus: Patients in the Republic of Korea find the medical staff attentive and the diagnostic equipment excellent. They note that fast access to specialists provides a positive outlook during treatment. Clear multidisciplinary plans also improve their experience.
What cutting-edge oncology technologies are routinely utilised for cancer treatment in the Republic of Korea?
South Korea routinely uses heavy ion therapy, proton beam therapy, and da Vinci robotic systems for cancer care. Major centres like Severance Hospital and Samsung Medical Center integrate these with AI-driven diagnostics. Multidisciplinary teams use precision genetic profiling to tailor immunotherapy and targeted drug regimens.
- Particle therapy: Yonsei Cancer Center uses carbon-ion therapy to deliver energy to deep-seated tumours.
- Robotic surgery: Surgeons at Severance Hospital use the da Vinci system for minimally invasive oncologic procedures.
- Precision radiation: Samsung Medical Center employs Novalis and image-guided radiation therapy to spare healthy tissue.
- Digital infrastructure: Seoul National University Bundang Hospital uses the BESTcare system for integrated digital health records.
Bookimed Expert Insight: Samsung Medical Center serves over 2,000,000 patients annually and performs 45,000+ operations. This massive volume allows their doctors to maintain rare proficiency in robotic and particle therapies. For Australian patients, this level of clinical experience often exceeds what is available at smaller local units.
Patient Consensus: Patients in the Republic of Korea report that diagnostics like PET/CT and MRI are completed remarkably fast. They feel reassured by the professional translators and the hospital environments that offer hope during treatment.
What types of cancer are commonly treated by specialists in the Republic of Korea?
South Korean specialists frequently treat stomach, thyroid, lung, colorectal, breast, and liver cancers. These centres maintain exceptional success rates. They report a 77% survival rate for gastric cancer and nearly 100% for thyroid cases. High volumes at facilities like Samsung Medical Center drive clinical expertise in robotic and minimally invasive surgeries.
- Stomach cancer: Global leadership in endoscopic resections and proprietary reflux-reducing surgical techniques.
- Thyroid cancer: Routine management using radioiodine therapy and specialised resections with high outcomes.
- Breast cancer: Pioneer status in breast-conserving surgery and robotic-assisted oncoplastic reconstructions.
- Colorectal cancer: Frequent use of Da Vinci robotic systems for precise laparoscopic tumour removal.
Bookimed Expert Insight: Data suggests Korea is the global benchmark for gastric cancer. This is because specialists there handle unparalleled case volumes. For example, Samsung Medical Center treats over 2,000,000 patients annually. This throughput allows doctors like Prof. Dr Paik Nam-sun to develop proprietary surgical methods. These techniques specifically reduce post-operative complications like reflux disease.
Patient Consensus: Patients in South Korea appreciate the professional translators and streamlined diagnostics. They note that multiple tests often begin the day they arrive. Many highlight the impressive equipment and the comfort of multidisciplinary care for breast or gastric cancers.
What are the requirements for bringing diagnostic scans and pathology reports to oncology centres in the Republic of Korea?
Oncology centres in the Republic of Korea require original diagnostic images in DICOM format on a CD or USB. Patients must also provide official pathology reports in English or Korean. Doctors often require physical tissue slides or paraffin blocks for local re-testing to confirm staging.
- Imaging recency: Most centres require CT, MRI, or PET-CT scans taken within 6 months.
- Digital format: Hospitals need full DICOM files rather than static JPEGs or printed images.
- Pathology requirements: Patients must bring 1 stained and 10 unstained tissue slides for verification.
- Documentation standards: All medical summaries and interpretation reports must be in English or Korean.
Bookimed Expert Insight: Top Seoul centres like Seoul National University Bundang Hospital use the BESTcare digital system. This allows staff to upload external CD files into local systems instantly. Patients should arrive 15 minutes early to allow this digital integration. This avoids delays during the specialist consultation.
Patient Consensus: Patients note that bringing duplicate sets of original DICOM files and pathology blocks is essential. Korean doctors often perform a thorough third opinion. They use original files rather than just summaries for precise treatment planning.
Is it possible to receive traditional integrated therapies during oncology treatment in the Republic of Korea?
Traditional integrated therapies are widely available in the Republic of Korea. A dual medical system allows modern oncology and Traditional Korean Medicine (TKM) to coexist legally. Major university hospitals combine chemotherapy with acupuncture, herbal medicine, and moxibustion to manage side effects.
- Integrated frameworks: Modern hospitals collaborate with TKM doctors to manage chemotherapy-induced nausea and pain.
- Specific modalities: Acupuncture, pharmacopuncture, and tailored herbal prescriptions are standard supportive therapies.
- Accredited facilities: JCI-accredited centres like Severance Hospital and Samsung Medical Center offer multidisciplinary care.
- Clinical pathways: Dedicated departments often provide heat therapies and medicinal diets to boost patient immunity.
Bookimed Expert Insight: Many Australians focus on Seoul. However, Incheon-based centres like Na-Eun Hospital and Gachon University Gil Medical Center handle 20,000 to 38,000 patients annually. These facilities often offer faster access to multidisciplinary consultations. Speed is critical when coordinating Western treatments with traditional supportive therapies. This helps to confirm they do not interfere with chemotherapy cycles.
Patient Consensus: Patients in the Republic of Korea find the transition between diagnostic tests and traditional support seamless. This is due to professional interpreters and efficient hospital transfers. They note that doctors provide a positive outlook using integrated care plans.
What are the requirements for caregivers during an oncology hospital stay in the Republic of Korea?
Caregivers in Republic of Korea oncology wards are known as guardians. They must follow strict rules based on the ward type. Standard wards require one adult guardian present 24/7 to help with daily living. Comprehensive nursing wards prohibit overnight family stays. In these wards, hospital staff handle all hygiene and mobility tasks.
- Guardian pass: Hospitals issue one permit per patient for 24/7 ward access.
- Health screening: Caregivers often need a negative tuberculosis chest X-ray before admission.
- Bedside duties: Standard ward guardians manage feeding, washing, and escorting patients to tests.
- Private hiring: Families can hire professional caregivers (Ganbyeongin) for out-of-pocket bedside support.
Bookimed Expert Insight: Samsung Medical Center and Severance Hospital use digital systems like BESTcare to track patient needs. Patients in 5-bed rooms often report high satisfaction when using these integrated nursing services. These wards remove the need for family to provide physical labour. However, they require formal consent to follow staff-led care protocols.
Patient Consensus: Patients find the hospital environment professional. They note that translators stay nearby during complex diagnostics. While ward conditions vary, constant attention from medical staff provides security during intensive treatment in Republic of Korea.























